Cargando…
Midkine promotes glioblastoma progression via PI3K-Akt signaling
BACKGROUND: Our previous bioinformatics-based study found that midkine (MDK) was associated with poor prognosis of glioblastoma (GBM). However, the mechanism of MDK in GBM remains elusive. METHODS: A public GBM-related dataset and GBM tissues from our center were used validate the aberrant expressio...
Autores principales: | Hu, Beiquan, Qin, Chao, Li, Li, Wei, Lei, Mo, Xianlun, Fan, Huasheng, Lei, Yuanhua, Wei, Feng, Zou, Donghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461913/ https://www.ncbi.nlm.nih.gov/pubmed/34556138 http://dx.doi.org/10.1186/s12935-021-02212-3 |
Ejemplares similares
-
YY1 activates EMI2 and promotes the progression of cholangiocarcinoma through the PI3K/Akt signaling axis
por: Zhou, Shuai, et al.
Publicado: (2021) -
Decreased therapeutic effects of noscapine combined with imatinib mesylate on human glioblastoma in vitro and the effect of midkine
por: Erguven, Mine, et al.
Publicado: (2011) -
Benzimidazoisoquinoline derivatives inhibit glioblastoma cell proliferation through down-regulating Raf/MEK/ERK and PI3K/AKT pathways
por: Zhang, Ya-Jun, et al.
Publicado: (2018) -
Aloperine inhibits the progression of non-small-cell lung cancer through the PI3K/Akt signaling pathway
por: Liu, Fujuan, et al.
Publicado: (2021) -
NEDD4L-induced ubiquitination mediating UBE2T degradation inhibits progression of lung adenocarcinoma via PI3K-AKT signaling
por: Chen, Yongbing, et al.
Publicado: (2021)